By accessing our website, you accept cookies Hide this message

Which patients can be treated with HIFU?

 

Patients who have not yet received any treatment for cancer

HIFU treatment for localized prostate cancer is especially relevant for total or radical treatment of the entire prostate gland for patients with:

  • A localized stage T1 or T2 cancer

  • A Gleason score of 7 or less

  • A desire to maintain maximum quality of life after treatment

It is also possible to treat more aggressive cancers (Gleason score  higher than 7) with a urologist expert of the technique.

Patients seeking an innovative approach: focal HIFU treatment

Focal One® is the ideal tool to treat just the diseased area inside the prostate in order to preserve maximum quality of life (limited impact on neighbouring organs reduces side effects). This therapeutic approach aims to achieve a control of the disease by closely monitoring the patient and repeating the treatment if necessary. This innovative therapeutical option is currently under investigation and the first results show a perfect preservation of sexual and urinary functions. Focal therapy is an intermediate response between active surveillance and radical treatments: cancer is effectively treated but minimally invasively, preserving quality of life of the patients and lifting the psychological stress that active surveillance can represent to the patient.

Patients who have already received HIFU treatment

All patients who have received a HIFU treatment for localized prostate cancer can receive repeat treatments in case the original treatment's outcome justifies it. Repeated treatment option is not available with conventional options as radiotherapy or surgical treatments.

Patients who have already received radiotherapy

When a patient has already received radiotherapy treatment for localized prostate cancer but the cancer has recurred, range of therapeutical options is limited but HIFU treatment represents an excellent "second chance".
HIFU treatment eligibility criteria:

  • Localized (i.e. within the gland) recurrence of the cancer has been detected

  • The staging assessment is clear, i.e. the cancer is still totally contained within the prostate

HIFU prostate cancer treatment contraindications:

  • Anal or rectal surgery that prevents insertion of the probe

  • Artificial sphincter, penile implants and intra-prostatic implants

  • Allergy to latex.

 

 

Last update 14 febuary 2017.

Talking about HIFU

Discuss about HIFU with your general practionner

  • Glossary
  • Cancer
    Abnormal cells that develop in an uncontrolled manner. An accumulation of such cells is known as a tumor.
  • Gland
    Small organ that produces one or more substances in the body.
  • Gleason
    See Gleason score
  • Prostate
    Gland in the male genital system that plays a role in semen production.
  • Recurrence
    Reappearance of signs indicating the presence of cancer following a period of remission.
  • Side effect
    Generally adverse secondary consequence of a treatment.
  • Sphincter
    Ring of muscle around a natural orifice, allowing the orifice to open and close. - The urinary sphincter, located at the prostate outlet, controls the retention and release of urine. - The anal sphincter controls the retention and release of stools.
  • Urologist
    Physician who specializes in urinary and genital conditions.
Back to top